Literature DB >> 16047062

Screening program for prostate cancer at a university hospital in eastern Saudi Arabia.

Saud A Taha1, Baher A Kamal.   

Abstract

OBJECTIVE: Implementation of a pilot screening program for prostate cancer among Saudi patients that would serve as a nucleus for a Kingdom-wide screening program.
METHODS: A prospective study on 1,213 Saudi males between 50-80 years of age who attended the Outpatient Department at King Fahd Hospital of King Faisal University, Al-Khobar, Kingdom of Saudi Arabia during a period of 18 months (April 2001-October 2002). They were included at random from different clinics including the urology clinic. Free and total prostate specific antigen (PSA), and digital rectal examination (DRE) of the prostate were performed in all patients. Patients with abnormal DRE or PSA were scheduled for transrectal ultrasound (TRUS) and ultrasound guided biopsy of the prostate.
RESULTS: Abnormal DRE or PSA were present in 84 out of 1,213 patients. Only 63 patients agreed to have TRUS and ultrasound guided biopsies. Prostate cancer was confirmed in 14 out of 1,192 patients who completed the study (1.17%).
CONCLUSION: The incidence of prostate cancer among Saudi men in this hospital based study is low. A population based screening for prostate cancer may reveal the incidence of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047062

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  2 in total

1.  An early-detection programme for prostate cancer in Saudi men: A call from a tertiary-care centre in the Eastern province.

Authors:  Elsawi Osman; Mohamed A Gomha; Ahmed Harb; Adel Aldayel; Ibrahim Aloraifi; Riyad Almousa; Irfan Khan
Journal:  Arab J Urol       Date:  2014-05-13

Review 2.  With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?

Authors:  Mostafa A Arafa; Danny M Rabah
Journal:  World J Clin Oncol       Date:  2017-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.